Growth-focused healthcare and life sciences private investment firm Petrichor has named Paul J Sekhri as Operating Partner, bolstering its team with an executive who brings more than 35 years of experience across biotech and pharmaceutical sectors.
Sekhri, currently Chairman, President, and CEO of vTv Therapeutics, has held senior leadership positions at eGenesis, Lycera Corporation, and Cerimon Pharmaceuticals, in addition to strategic roles at Sanofi, Teva, TPG Biotech, ARIAD Pharmaceuticals,...
Continue Reading
Sign up for FREE to read the full article and access 131K+ alternative investment headlines.